Form 4: Collegium Pharmaceutical EVP Colleen Tupper Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Colleen Tupper, EVP & CFO of Collegium Pharmaceutical, sold 19,710 shares of common stock at a weighted average price of $34.2145 under a pre-arranged 10b5-1 trading plan.
Summary
- On May 28, 2024, Colleen Tupper, the EVP & Chief Financial Officer of Collegium Pharmaceutical, sold 19,710 shares of common stock.
- The sale was executed under a Rule 10b5-1 trading plan adopted on February 26, 2024.
- The shares were sold at a weighted average price of $34.2145, with individual transactions ranging from $33.94 to $34.47.
- Following the transaction, Tupper directly owns 130,845 shares of Collegium Pharmaceutical.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a stock sale by an executive under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment.
Industry Context
Executive stock sales are a common occurrence and are often pre-planned to avoid accusations of insider trading. The use of a 10b5-1 trading plan allows insiders to sell shares at predetermined times and prices.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.
Key Dates
| Date | Description |
|---|---|
| February 26, 2024 | Date the reporting person adopted the Rule 10b5-1 trading plan |
| May 28, 2024 | Date of the stock sale transaction |
| May 29, 2024 | Date of the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.